Company profile for Guardian Drug Company

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Guardian Drug Company is a leading consumer healthcare organization that develops, manufactures and distributes pharmaceutical and nutritional products through various distribution channels from our state of the art facility located in Dayton, New Jersey. Our primary focus is to deliver quality products with great customer service at competitive prices. We are pioneers in the over-the-counter gastrointestinal products. Guardi...
Guardian Drug Company is a leading consumer healthcare organization that develops, manufactures and distributes pharmaceutical and nutritional products through various distribution channels from our state of the art facility located in Dayton, New Jersey. Our primary focus is to deliver quality products with great customer service at competitive prices. We are pioneers in the over-the-counter gastrointestinal products. Guardian Drug Company is an approved contract manufacturer for some of the pharmaceutical majors in the country.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2 Charles Court Dayton, NJ 08810USA
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

PEGS Boston Summit

PEGS Boston Summit

Not Confirmed

envelop Contact Supplier

PEGS Boston Summit

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219009

FDA
11 Jul 2025

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214892

FDA
30 Dec 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214541

FDA
30 May 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210149

FDA
22 Aug 2018

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/taparias-to-pick-majority-stake-in-guardian-pharmacy-chain/articleshow/53860234.cms

ECONOMIC TIMES
25 Aug 2016

FDF Dossiers

read-more
read-more

01

Brand Name : FOAMCOAT

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : FOAMCOAT

arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

Dosage Form : TABLET, CHEWABLE;ORAL

Brand Name : FOAMCOAT

Dosage Strength : 80MG;20MG

Packaging :

Approval Date : 1987-09-04

Application Number : 71793

Regulatory Info : DISCN

Registration Country : USA

blank

02

Brand Name : BISMUTH SUBSALICYLAT...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : BISMUTH SUBSALICYLAT...

arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

Dosage Form : SUSPENSION

Brand Name : BISMUTH SUBSALICYLATE SUS...

Dosage Strength : 17.5MG/ML

Packaging : 230ML/480ML

Approval Date :

Application Number : 2313162

Regulatory Info : NON-PRESCRIPTION DRUGS

Registration Country : Canada

blank

03

Brand Name : BISMUTH SUBSALICYLAT...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : BISMUTH SUBSALICYLAT...

arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

Dosage Form : TABLET

Brand Name : BISMUTH SUBSALICYLATE CAP...

Dosage Strength : 262MG

Packaging : 24

Approval Date :

Application Number : 2326582

Regulatory Info : NON-PRESCRIPTION DRUGS

Registration Country : Canada

blank

04

Brand Name : EXTRA STRENGTH BISMU...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : EXTRA STRENGTH BISMU...

arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

Dosage Form : SUSPENSION

Brand Name : EXTRA STRENGTH BISMUTH SU...

Dosage Strength : 35MG/ML

Packaging : 236/350/473ML

Approval Date :

Application Number : 2328453

Regulatory Info : NON-PRESCRIPTION DRUGS

Registration Country : Canada

blank

05

Brand Name : STOMACH RELIEF CHEWA...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : STOMACH RELIEF CHEWA...

arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

Dosage Form : TABLET (CHEWABLE)

Brand Name : STOMACH RELIEF CHEWABLE T...

Dosage Strength : 262MG

Packaging : 24/48

Approval Date :

Application Number : 2389215

Regulatory Info : NON-PRESCRIPTION DRUGS

Registration Country : Canada

blank

06

Brand Name : STOMACH RELIEF CHEWA...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : STOMACH RELIEF CHEWA...

arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

Dosage Form : TABLET (CHEWABLE)

Brand Name : STOMACH RELIEF CHEWABLE T...

Dosage Strength : 350MG

Packaging : 24/48

Approval Date :

Application Number : 2389215

Regulatory Info : NON-PRESCRIPTION DRUGS

Registration Country : Canada

blank

07

Brand Name : ESOMEPRAZOLE MAGNESI...

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : ESOMEPRAZOLE MAGNESI...

arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

Dosage Form : CAPSULE, DELAYED RELEASE...

Brand Name : ESOMEPRAZOLE MAGNESIUM

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2023-03-15

Application Number : 216149

Regulatory Info : OTC

Registration Country : USA

blank

08

Brand Name : GUAIFENESIN

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : GUAIFENESIN

arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

Dosage Form : TABLET, EXTENDED RELEASE...

Brand Name : GUAIFENESIN

Dosage Strength : 600MG

Packaging :

Approval Date : 2017-09-06

Application Number : 209215

Regulatory Info : OTC

Registration Country : USA

blank

09

Brand Name : GUAIFENESIN

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : GUAIFENESIN

arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

Dosage Form : TABLET, EXTENDED RELEASE...

Brand Name : GUAIFENESIN

Dosage Strength : 1.2GM

Packaging :

Approval Date : 2017-09-06

Application Number : 209215

Regulatory Info : OTC

Registration Country : USA

blank

10

Brand Name : IBUPROFEN

PEGS Boston Summit
Not Confirmed
arrow

Brand Name : IBUPROFEN

arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

Dosage Form : SUSPENSION;ORAL

Brand Name : IBUPROFEN

Dosage Strength : 100MG/5ML

Packaging :

Approval Date : 2018-08-17

Application Number : 210149

Regulatory Info : OTC

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

Inspections and registrations

Upload your audits for free, ask us

FDA

read-more
read-more

01

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

City : Dayton

State : New Jersey

Country/Area : U.S.A

Zip : 8810

District :

Center :

Project Area : Bioresearch Monitoring

District Decision : No Action Indicated

Inspection End Date : 2024-11-07

blank

02

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

City : Dayton

State : New Jersey

Country/Area : U.S.A

Zip : 8810

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2022-02-17

blank

03

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

City : Dayton

State : New Jersey

Country/Area : U.S.A

Zip : 8810

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-11-06

blank

04

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

City : Dayton

State : NJ

Country/Area : U.S.A

Zip : 08810-1508

District : NWJ

Center : CFSAN

Project Area : Food Composition, Standards, Lab...

District Decision : No Action Indicated

Inspection End Date : 2014-08-15

blank

05

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

City : Dayton

State : New Jersey

Country/Area : U.S.A

Zip : 8810

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2014-08-15

blank

06

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

City : Dayton

State : NJ

Country/Area : U.S.A

Zip : 08810-1508

District : NWJ

Center : CFSAN

Project Area : Food Composition, Standards, Lab...

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-06-08

blank

07

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

City : Dayton

State : New Jersey

Country/Area : U.S.A

Zip : 8810

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-06-08

blank

08

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

City : Dayton

State : New Jersey

Country/Area : U.S.A

Zip : 8810

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-03-02

blank

09

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

City : Dayton

State : New Jersey

Country/Area : U.S.A

Zip : 8810

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2011-02-18

blank

10

FDA Audited

USA
PEGS Boston Summit
Not Confirmed
arrow

FDA Audited

USA
arrow
PEGS Boston Summit
Not Confirmed

Guardian Drug Company

City : Dayton

State : New Jersey

Country/Area : U.S.A

Zip : 8810

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2008-10-28

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

GDUFA

read-more
read-more

01

GDUFA fees paid

USA
PEGS Boston Summit
Not Confirmed
arrow

GDUFA fees paid

USA
arrow
PEGS Boston Summit
Not Confirmed

API Manufacturer :

FDF Manufacturer : FDF MANUFACTURE

Facility Name : Guardian Drug Company Inc.

Business Address : 2 Charles court Dayton NJ 08...

FEI Number : 2245306

Country : U.S.A

Paid in : 2019

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty